RACHEL KOKAL: Open Payments
NPI 1144644774 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,959 in 93 payments from 19 companies in 2025. Trend: 2023 $1,756 · 2024 $1,190 · 2025 $1,959
Food & beverage: $1,859Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $399 |
| ABBVIE INC. | 20 | $357 |
| GENZYME CORPORATION | 5 | $149 |
| UCB, Inc. | 4 | $116 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Organon LLC | 4 | $99 |
| LEO Pharma Inc. | 3 | $98 |
| Amgen Inc. | 5 | $91 |
| Galderma Laboratories, L.P. | 5 | $90 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Bimzelx, COSENTYX, Otezla, RINVOQ, AKLIEF.
Industry payments across VA — which companies pay providers there.
